Companies / Brazil
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
ARV Manufacturing Gets Green Light
January 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
A long-delayed pharmaceutical plant that would provide Mozambique with the capacity to manufacture generic antiretrovirals (ARVs) looks set to be built with support from the Brazilian government. Back in 2003 Brazil's President Luiz Inácio Lula da Silva promised his country's support in establishing an ARV factory in Mozambique. Following a feasibility study, authorities have concluded that construction should